Loading clinical trials...
Loading clinical trials...
Long-Term Open-Label Primary Vaccination and Booster Dose Study of the Safety and Immunogenicity of Rift Valley Fever Vaccine, Inactivated, Dried (TSI-GSD 200) in At-Risk Adults
Conditions
Interventions
Inactivated, Dried (TSI-GSD 200), RVF Vaccine
Locations
1
United States
U.S. Army Medical Research Institute of Infectious Diseases
Fort Deterick, Maryland, United States
Start Date
September 1, 2009
Primary Completion Date
February 1, 2019
Completion Date
May 1, 2021
Last Updated
March 4, 2022
NCT05139524
NCT00415051
NCT00287014
Lead Sponsor
U.S. Army Medical Research and Development Command
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions